Post-Translational Modifications of Nuclear Co-repressor RIP140: A Therapeutic Target for Metabolic Diseases

E-ISSN： 1875-533x|15|4|386-392

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.4, 2008-02, pp. : 386-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Post-translational Modifications to Target Memory-related Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5065-5075

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite

Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens

By Papanastasiou Anastasios D Chatzantoni Kokona Mouzaki Athanasia

Expert Opinion on Drug Discovery, Vol. 3, Iss. 10, 2008-10 ,pp. : 1255-1265

Informa Healthcare

Access to resources Recommend Favorite

Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5085-5092

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 714-745

Bentham Science Publishers

Access to resources Recommend Favorite